Partner Dan Shores will lead a workshop titled "Navigating IP Challenges for Companies Utilizing Lipid Nanoparticle Delivery Systems to Enable Freedom to Operate & Mitigate Infringement Risk" at the 4th Annual LNP Formulation & Process Development Summit taking place April 14-16, 2025, in Boston, Massachusetts. Dan's workshop will take place on May 4 during the Pre-Conference Workshop Day.
As securing IP and avoiding patent infringements remain key challenges for the LNP community, this workshop will help you tackle these obstacles, strengthen your due diligence strategy, and enhance IP compliance. The workshop will cover:
- How to ensure you have high quality patent protection earlier in the drug development pipeline;
- How to strategically identify lipids which are available to use which won’t cause patent infringement;
- An overview of key freedom to operate challenges facing therapeutic developers operating in this space; and
- Advanced solution-based strategies for de-risking the therapeutic program from an IP perspective.
The 4th LNP Formulation & Process Development Summit returns to Boston, as the only industry summit dedicated to showcasing the hottest pre-clinical and clinical data, overcoming the greatest challenges within the LNP IP space, and uncovering the most innovative LNP formulations for cell-specific delivery outside the liver. With a revamped track design, the 2025 meeting has three dedicated streams, Analytical Development & Characterization, Formulation & Delivery, and Process Development & Manufacturing, to deep dive into an end-to-end strategy for revolutionizing the development of potent, safe, and stable LNPs for a variety of payloads. Uniting 300+ LNP trailblazers from across the globe, this is your one-stop-shop for LNP specific networking, partnership opportunities, and collaborative discussions to further fuel advancement of LNPs towards clinical development and beyond.
To learn more about the event, and to register, please visit the event website.
